Scientific article
OA Policy
English

The ADAPP trial: a two-year longitudinal multidisciplinary intervention study for prostate cancer frail patients on androgen deprivation associated to curative radiotherapy

Published in

Acta Oncologica, vol. 56, no. 4, p. 569-574

Publication date

2017

Abstract

Androgen deprivation (AD) therapy combined to radiotherapy (RT) is a curative therapeutic option for patients with non-metastatic locally advanced or aggressive intermediate prostate cancer (PC), though with a range of nutritional, physical, and psychological side effects. A multidisciplinary care program was created to help frail patients to prevent and manage those side effects.

Keywords

  • Aged
  • Androgen Antagonists/administration & dosage/adverse effects
  • Chemoradiotherapy/adverse effects
  • Counseling
  • Frail Elderly
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Physical Therapy Modalities
  • Prostatic Neoplasms/psychology/rehabilitation/therapy
  • Psychotherapy
  • Quality of Life

Citation (ISO format)

MARESCHAL, Julie et al. The ADAPP trial: a two-year longitudinal multidisciplinary intervention study for prostate cancer frail patients on androgen deprivation associated to curative radiotherapy. In: Acta Oncologica, 2017, vol. 56, n° 4, p. 569–574. doi: 10.1080/0284186X.2016.1273545

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0284-186X
624views
406downloads

Technical informations

Creation

13/11/2017 14:32:00

First validation

13/11/2017 14:32:00

Update

15/03/2023 02:20:01

Status update

15/03/2023 02:20:00

Last indexation

31/10/2024 08:32:23
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated